Literature DB >> 16246514

Proteasome dysfunction in mammalian aging: steps and factors involved.

Niki Chondrogianni1, Efstathios S Gonos.   

Abstract

Mammalian aging is a natural biological process, determined by both genetic and environmental/stochastic factors, that results in the gradual decline of physiological function and the eventual failure of organism homeostasis. The proteasome is one of the major proteolytic systems of mammalian cells. It is responsible for the degradation of normal proteins as well as of abnormal proteins (like misfolded and oxidized proteins) that tend to accumulate during aging. Impaired proteasome function has been tightly correlated with aging both in vivo and in vitro. Given the fundamental function of proteasome for retaining cellular homeostasis, this review article examines the steps and the factors involved in proteasome dysfunction during mammalian aging. We discuss the proteasome structural organization, its activities and biosynthesis during aging and senescence as well as the genetic and environmental causes of its age-dependent alterations. Finally, we provide insights on the possibilities of proteasome activation that may retard the appearance of the senescent phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246514     DOI: 10.1016/j.exger.2005.09.004

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  45 in total

Review 1.  Degradation of damaged proteins: the main function of the 20S proteasome.

Authors:  Andrew M Pickering; Kelvin J A Davies
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  The biology of aging and frailty.

Authors:  Neal S Fedarko
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 3.  Protein stress and stress proteins: implications in aging and disease.

Authors:  C Söti; Péter Csermely
Journal:  J Biosci       Date:  2007-04       Impact factor: 1.826

4.  Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.

Authors:  Nicholas MacInnes; Mahmoud M Iravani; Elaine Perry; Margaret Piggott; Robert Perry; Peter Jenner; Clive Ballard
Journal:  J Neural Transm (Vienna)       Date:  2008-04-10       Impact factor: 3.575

5.  Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts.

Authors:  Suzanne Kapeta; Niki Chondrogianni; Efstathios S Gonos
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

6.  Proteasome inhibition modulates kinase activation in neural cells: relevance to ubiquitination, ribosomes, and survival.

Authors:  Le Zhang; Philip J Ebenezer; Kalavathi Dasuri; Annadora J Bruce-Keller; Ying Liu; Jeffrey N Keller
Journal:  J Neurosci Res       Date:  2009-11-01       Impact factor: 4.164

7.  Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process.

Authors:  Ayako Tonoki; Erina Kuranaga; Takeyasu Tomioka; Jun Hamazaki; Shigeo Murata; Keiji Tanaka; Masayuki Miura
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

8.  Decreased proteasomal function accelerates cigarette smoke-induced pulmonary emphysema in mice.

Authors:  Yosuke Yamada; Utano Tomaru; Akihiro Ishizu; Tomoki Ito; Takayuki Kiuchi; Ayako Ono; Syota Miyajima; Katsura Nagai; Tsunehito Higashi; Yoshihiro Matsuno; Hirotoshi Dosaka-Akita; Masaharu Nishimura; Soichi Miwa; Masanori Kasahara
Journal:  Lab Invest       Date:  2015-04-27       Impact factor: 5.662

9.  Degradation of functional triose phosphate isomerase protein underlies sugarkill pathology.

Authors:  Jacquelyn L Seigle; Alicia M Celotto; Michael J Palladino
Journal:  Genetics       Date:  2008-05-05       Impact factor: 4.562

10.  Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation.

Authors:  Sarah J Cullen; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Biochem Pharmacol       Date:  2009-10-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.